Methylergonovine
routine management of uterine atony, hemorrhage and subinvolution of the uterus, control of uterine hemorrhage in the second stage of labor
Indications
- routine management of uterine atony, hemorrhage and subinvolution of the uterus
- control of uterine hemorrhage in the second stage of labor
Adult dosing
- im injection: dose: 0.2; unit: mg; route: IM; interval: after delivery of anterior shoulder or placenta, every 2-4 hours; fixed: true; labelExcerpt: Intramuscularly 1 mL, 0.2 mg, after delivery of the anterior shoulder, after delivery of the placenta, or during the puerperium. May be repeated as required, at intervals of 2 to 4 hours.
- iv injection: dose: 0.2; unit: mg; route: IV; interval: single dose; fixed: true; labelExcerpt: Intravenously 1 mL, 0.2 mg, administered slowly over a period of no less than 60 seconds
- oral puerperium: dose: 0.2; unit: mg; route: PO; interval: 3 or 4 times daily for max 1 week; fixed: true; labelExcerpt: Orally The recommended dosage of methylergonovine maleate is One tablet, 0.2 mg, orally 3 or 4 times daily in the puerperium for a maximum of 1 week.
Pediatric dosing
- Consult pharmacy/current label
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Caution should be exercised in the presence of impaired hepatic function.
Contraindications
- Hypertension
- Toxemia
- Pregnancy
- Hypersensitivity
Clinical pearls
- Do not administer IV routinely due to risk of sudden hypertensive or cerebrovascular accidents.
- If IV administration is essential, inject slowly over at least 60 seconds with blood pressure monitoring.
- Store separately from neonatal medications to prevent accidental infant administration.
- Patients with coronary artery disease may be at increased risk of myocardial ischemia.
Source and review
- DailyMed label (methylergonovine maleate), Set ID 4ddcdfff-1468-bff0-e063-6294a90a5480, effective 2026-03-25. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties